Linking resistin, inflammation, and cardiometabolic diseases

키워드

참고문헌 (66)

1. Steppan CM, "The hormone resistin links obesity to diabetes", Nature, 409, pp.307~312 (2001)
2. Patel L, "Resistin is expressed in human macrophages and directly regulated by PPAR gamma activat", Biochem Biophys Res Commun, 300, pp.472~476 (2003)
3. Patel SD, "Disulfide-dependent multimeric assembly of resistin family hormones", Science, 304, pp.1154~1158 (2004)
4. Tomaru T, "Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT", enhancer-binding proteins, 2009, pp.284, 6116~6125
5. Schwartz DR, "Human resistin: found in translation from mouse to man", Trends Endocrinol Metab, 22, pp.259~265 (2011)
6. 박형규, "Resistin in Rodents and Humans", Diabetes and Metabolism Journal, 37(6), pp.404~414 (2013), 대한당뇨병학회[DOI]
7. Novick D, "Heparanase interacts with resistin and augments its activity", PLoS One, 9, pp.e85944~ (2014)
8. Lazar MA., "Resistin- and obesity-associated metabolic diseases", Horm Metab Res, 39, pp.710~716 (2007)
9. Song R, "Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3beta", Gene, 529, pp.50~56 (2013)
10. Daquinag AC, "An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells", Cell Stem Cell, 9, pp.74~86 (2011)
11. Sanchez-Solana B, "Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1preadipocytes through the ROR1 receptor", Mol Endocrinol, 26, pp.110~127 (2012)
12. Banerjee RR, "Regulation of fasted blood glucose by resistin", Science, 303, pp.1195~1198 (2004)
13. Satoh H, "Adenovirus-mediated chronic “hyper-resistinemia”leads to in vivo insulin resistance in normal rats", J Clin Invest, 114, pp.224~231 (2004)
14. Muse ED, "Role of resistin in diet-induced hepatic insulin resistance", J Clin Invest, 114, pp.232~239 (2004)
15. Birnbaum MJ, "Activation of SOCS-3 by resistin", Mol Cell Biol, 25, pp.1569~1575 (2005)
16. Filkova M, "The role of resistin as a regulator of inflammation: Implications for various human pathologies", Clin Immunol, 133, pp.157~170 (2009)
17. Jamaluddin MS, "Resistin:functional roles and therapeutic considerations for cardiovascular disease", Br J Pharmacol, 165, pp.622~632 (2012)
18. Bokarewa M, "Resistin, an adipokine with potent proinflammatory properties", J Immunol, 174, pp.5789~5795 (2005)
19. Jung HS, "Resistin is secreted from macrophages in atheromas and promotes atherosclerosis", Cardiovasc Res, 69, pp.76~85 (2006)
20. Hsu WY, "Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway", J Cell Physiol, 226, pp.2181~2188 (2011)
21. Manduteanu I, "Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells", Biochem Biophys Res Commun, 391, pp.1443~1448 (2010)
22. Jamaluddin MS, "Resistin increases monolayer permeability of human coronary artery endothelial cells", PLoS One, 8, pp.e84576~ (2013)
23. Chen C, "Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells", Am J Physiol Heart Circ Physiol, 299, pp.H193~H201 (2010)
24. Qiu W, "Resistin increases platelet P-selectin levels via p38 MAPK signal pathway", Diab Vasc Dis Res, 11, pp.121~124 (2014)
25. Codoner-Franch P, "Resistin: insulin resistance to malignancy", Clin Chim Acta, 438, pp.46~54 (2015)
26. Huang X, "Resistin’s, obesity and insulin resistance:the continuing disconnect between rodents and humans", J Endocrinol Invest, 39, pp.607~615 (2016)
27. Qatanani M, "Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice", J Clin Invest, 119, pp.531~539 (2009)
28. Park HK, "Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice", Diabetes, 60, pp.775~783 (2011)
29. Graveleau C, "Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action", J Biol Chem, 280, pp.31679~31685 (2005)
30. Sheng CH, "Human resistin inhibits myogenic differentiation and induces insulin resistance in myocytes", Biomed Res Int, 2013, pp.804632~ (2013)
31. Luo Z, "Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells", Endocrine, 36, pp.60~69 (2009)
32. Chen BH, "Circulating levels of resistin and risk of type 2 diabetes in men and women:results from two prospective cohorts", Diabetes Care, 32, pp.329~334 (2009)
33. Tarkowski A, "Resistin competes with lipopolysaccharide for binding to toll-like receptor 4", J Cell Mol Med, 14(6B), pp.1419~1431 (2010)
34. Lee S, "Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes", Cell Metab, 19, pp.484~497 (2014)
35. Benomar Y, "Central resistin overexposure induces insulin resistance through Tolllike receptor 4", Diabetes, 62, pp.102~114 (2013)
36. Ding Q, "Resistin and cardiovascular disease", Trends Cardiovasc Med, 21, pp.20~27 (2011)
37. Lee SH, "Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry", Coron Artery Dis, 20, pp.33~39 (2009)
38. Menzaghi C, "Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes", PLoS One, 8, pp.e64729~ (2014)
39. Khera AV, "On-statin resistin, leptin, and risk of recurrent coronary events after hospitalization for an acute coronary syndrome (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 study)", Am J Cardiol, 116, pp.694~698 (2015)
40. Wang BW, "Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-alpha", Am J Physiol Heart Circ Physiol, 293, pp.H2305~H2312 (2007)
41. Chemaly ER, "Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats", J Mol Cell Cardiol, 51, pp.144~155 (2011)
42. Gao J, "Resistin, an adipocytokine, offers protection against acute myocardial infarction", J Mol Cell Cardiol, 43, pp.601~609 (2007)
43. Rothwell SE, "Resistin worsens cardiac ischaemia-reperfusion injury", Biochem Biophys Res Commun, 349, pp.400~407 (2006)
44. Schwartz DR, "Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer", Endocrinology, 154, pp.4206~4214 (2013)
45. Menzaghi C, "Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians", J Clin Endocrinol Metab, 91, pp.2792~2795 (2006)
46. Osawa H, "Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population", Diabetes Care, 30, pp.1501~1506 (2007)
47. Cho YM, "Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans", Diabetologia, 47, pp.559~565 (2004)
48. Xu JY, "Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study", Clin Endocrinol (Oxf ), 66, pp.211~217 (2007)
49. El-Shal AS, "Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients", Gene, 515, pp.233~238 (2013)
50. Norata GD, "Plasma resistin levels correlate with determinants of the metabolic syndrome", Eur J Endocrinol, 156, pp.279~284 (2007)
51. Singh AK, "Association of resistin with metabolic syndrome in Indian subjects", Metab Syndr Relat Disord, 10, pp.286~291 (2012)
52. Owecki M, "Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans", Neuro Endocrinol Lett, 31, pp.673~678 (2010)
53. Cabrera de Leon A, "Relationships between serum resistin and fat intake, serum lipid concentrations and adiposity in the general population", J Atheroscler Thromb, 21, pp.454~462 (2014)
54. Abate N, "Resistin: an inflammatory cytokine: role in cardiovascular diseases, diabetes and the metabolic syndrome", Curr Pharm Des, 20, pp.4961~4969 (2014)
55. Costandi J, "Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling", Circ Res, 108, pp.727~742 (2011)
56. Rashid S, "PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia", Expert Rev Cardiovasc Ther, 11, pp.1567~1577 (2013)
57. Melone M, "Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin", kexin type 9, 2012, pp.59, 1697~1705
58. Horton JD, "PCSK9: a convertase that coordinates LDL catabolism", J Lipid Res, 50(Suppl), pp.S172~S177 (2009)
59. Hampton EN, "The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain", Proc Natl Acad Sci U S A, 104, pp.14604~14609 (2007)
60. Li S, "Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status", J Endocrinol Invest, 38, pp.1291~1299 (2015)
61. Kosari S, "Centrally administered resistin enhances sympathetic nerve activity to the hindlimb but attenuates the activity to brown adipose tissue", Endocrinology, 152, pp.2626~2633 (2011)
62. Badoer E, "Resistin, an adipokine with non-generalized actions on sympathetic nerve activity", Front Physiol, 6, pp.321~ (2015)
63. Takata Y, "Hyperresistinemia is associated with coexistence of hypertension and type 2diabetes", Hypertension, 51, pp.534~539 (2008)
64. Thomopoulos C, "Association of resistin and adiponectin with different clinical blood pressure phenotypes", J Hum Hypertens, 25, pp.38~46 (2011)
65. Papadopoulos DP, "Adiponectin:insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension", Blood Press, 17, pp.50~54 (2008)
66. Zhang L, "Plasma resistin levels associate with risk for hypertension among nondiabetic women", J Am Soc Nephrol, 21, pp.1185~1191 (2010)